Picture of Innogene Co logo

344860 Innogene Co Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapFalling Star

Annual balance sheet for Innogene Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments2,8183,19813,07213,34410,604
Net Total Accounts Receivable
Net Total Receivables1,0111,066995845664
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets5,0656,21615,47616,00713,045
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1,5191,4451,4121,2961,404
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets6,6687,94917,20017,54515,029
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1,1761,1751,144933920
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1,2631,2051,174933939
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity5,4056,74416,02616,61314,090
Total Liabilities & Shareholders' Equity6,6687,94917,20017,54515,029
Total Common Shares Outstanding